Cargando…
Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials
AST-120, an oral spherical activated carbon, may delay the need for kidney dialysis and improve uremia symptoms because it can adsorb acidic and basic organic compounds, especially small-molecule uremic toxins. However, previous studies produced no conclusive evidence regarding the benefits of AST-1...
Autores principales: | Su, Pei-Yu, Lee, Ya-Han, Kuo, Li-Na, Chen, Yen-Cheng, Chen, Chiehfeng, Kang, Yi-No, Chang, Elizabeth H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350440/ https://www.ncbi.nlm.nih.gov/pubmed/34381357 http://dx.doi.org/10.3389/fphar.2021.676345 |
Ejemplares similares
-
AST-120 for the management of progression of chronic kidney disease
por: Schulman, Gerald, et al.
Publicado: (2014) -
Review of the efficacy of AST-120 (KREMEZIN(®)) on renal function in chronic kidney disease patients
por: Asai, Mayumi, et al.
Publicado: (2019) -
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
por: Liu, Wen-Chih, et al.
Publicado: (2018) -
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
por: Velenosi, Thomas J., et al.
Publicado: (2016) -
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
por: Schulman, Gerald, et al.
Publicado: (2017)